4//SEC Filing
Fleming Harold Edward 4
Accession 0000950170-24-067321
CIK 0001674416other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:15 PM ET
Size
5.4 KB
Accession
0000950170-24-067321
Insider Transaction Report
Form 4
Fleming Harold Edward
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-30+13,000→ 13,000 totalExercise: $54.06Exp: 2034-05-30→ Common Shares (13,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001857250
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:15 PM ET
- Size
- 5.4 KB